JPRN-UMIN000006800
Recruiting
未知
'Smoldering' autoimmune inflammatory pathophysiology in epilepsies - Autoimmune inflammatory pathophysiology in epilepsies
Kyoto University School of Medicine0 sites50 target enrollmentJanuary 4, 2012
ConditionsEpilepsy
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Epilepsy
- Sponsor
- Kyoto University School of Medicine
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with dementia
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Therapy of antibody-mediated autoimmune diseases by Bortezomib (TAVAB)Myasthenia Gravis Systemic Lupus ErythematosusRheumatoid ArthritisTherapeutic area: Diseases [C] - Immune System Diseases [C20]EUCTR2013-005362-19-DECharité - Universitätsmedizin Berlin18
Recruiting
Not Applicable
Autoimmune inflammation as cause of RelapsIng Symptoms in patients with viral EncephalitisNL-OMON55224Academisch Medisch Centrum25
Recruiting
Not Applicable
To elucidate pathology of autoimmune disease and develop new treatmentautoimmune diseasesJPRN-UMIN000017559Keio University200
Recruiting
Not Applicable
Analysis for autoimmune components and the disease activity of interstitial pneumonia patientspatients with interstitial pneumoniaJPRN-UMIN000032926Dokkyo Medical University School of Medicine900
Recruiting
Not Applicable
Autoimmune-Lymphproliferative Primary Immunodeficiencies: A clinical, immunological and genetic cohort study (AL-PID study, formerly: ALPS study)Autoimmune Lymphoproliferative Syndrome other genetically defined or up to now not yet defined primary immunodeficienciesDRKS00011383niversitätsklinikum FreiburgCentrum für Chronische Immundefizienz (CCI)600